Brown Advisory’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $45.4M | Buy |
92,433
+3,214
| +4% | +$1.74M | 0.07% | 206 |
|
|
2025
Q4 | $51.7M | Buy |
89,219
+1,170
| +1% | +$662K | 0.07% | 189 |
|
|
2025
Q3 | $42.7M | Sell |
88,049
-7,886
| -8% | -$3.67M | 0.06% | 229 |
|
|
2025
Q2 | $38.9M | Sell |
95,935
-854,373
| -90% | -$357M | 0.05% | 230 |
|
|
2025
Q1 | $473M | Sell |
950,308
-47,867
| -5% | -$25.9M | 0.68% | 43 |
|
|
2024
Q4 | $519M | Sell |
998,175
-614,912
| -38% | -$338M | 0.66% | 40 |
|
|
2024
Q3 | $998M | Sell |
1,613,087
-48,278
| -3% | -$28.6M | 1.25% | 17 |
|
|
2024
Q2 | $919M | Sell |
1,661,365
-34,923
| -2% | -$20M | 1.2% | 18 |
|
|
2024
Q1 | $986M | Sell |
1,696,288
-198,007
| -10% | -$111M | 1.32% | 15 |
|
|
2023
Q4 | $1.01B | Sell |
1,894,295
-172,399
| -8% | -$83.4M | 1.41% | 14 |
|
|
2023
Q3 | $1.05B | Buy |
2,066,694
+12,463
| +0.6% | +$6.64M | 1.72% | 13 |
|
|
2023
Q2 | $1.07B | Buy |
2,054,231
+34,200
| +2% | +$18.5M | 1.67% | 12 |
|
|
2023
Q1 | $1.16B | Buy |
2,020,031
+11,480
| +0.6% | +$6.47M | 1.97% | 9 |
|
|
2022
Q4 | $1.11B | Sell |
2,008,551
-190,949
| -9% | -$101M | 2.05% | 5 |
|
|
2022
Q3 | $1.12B | Buy |
2,199,500
+153,451
| +7% | +$85.9M | 2.17% | 8 |
|
|
2022
Q2 | $1.11B | Sell |
2,046,049
-283,540
| -12% | -$156M | 2.09% | 7 |
|
|
2022
Q1 | $1.38B | Sell |
2,329,589
-210,243
| -8% | -$121M | 2.05% | 8 |
|
|
2021
Q4 | $1.69B | Buy |
2,539,832
+12,091
| +0.5% | +$7.55M | 2.1% | 8 |
|
|
2021
Q3 | $1.44B | Buy |
2,527,741
+109,975
| +5% | +$60.4M | 2.13% | 7 |
|
|
2021
Q2 | $1.16B | Sell |
2,417,766
-80,943
| -3% | -$38.2M | 1.75% | 11 |
|
|
2021
Q1 | $1.14B | Sell |
2,498,709
-5,031
| -0.2% | -$2.4M | 1.95% | 9 |
|
|
2020
Q4 | $1.17B | Sell |
2,503,740
-86,414
| -3% | -$40.5M | 2.07% | 8 |
|
|
2020
Q3 | $1.14B | Buy |
2,590,154
+104,188
| +4% | +$43M | 2.36% | 4 |
|
|
2020
Q2 | $901M | Buy |
2,485,966
+124,947
| +5% | +$41.9M | 2.1% | 8 |
|
|
2020
Q1 | $670M | Buy |
2,361,019
+17,923
| +0.8% | +$5.65M | 2.05% | 7 |
|
|
2019
Q4 | $761M | Buy |
2,343,096
+68,258
| +3% | +$20.7M | 1.93% | 6 |
|
|
2019
Q3 | $663M | Buy |
2,274,838
+89,782
| +4% | +$25.7M | 1.86% | 7 |
|
|
2019
Q2 | $642M | Buy |
2,185,056
+6,664
| +0.3% | +$1.84M | 1.84% | 9 |
|
|
2019
Q1 | $596M | Sell |
2,178,392
-25,298
| -1% | -$6.3M | 1.69% | 9 |
|
|
2018
Q4 | $493M | Sell |
2,203,690
-52,428
| -2% | -$12.3M | 1.66% | 13 |
|
|
2018
Q3 | $551M | Buy |
2,256,118
+200,713
| +10% | +$46.2M | 1.57% | 14 |
|
|
2018
Q2 | $426M | Sell |
2,055,405
-89,459
| -4% | -$19M | 1.31% | 20 |
|
|
2018
Q1 | $443M | Buy |
2,144,864
+49,320
| +2% | +$10.4M | 1.43% | 18 |
|
|
2017
Q4 | $398M | Sell |
2,095,544
-73,799
| -3% | -$14.1M | 1.26% | 22 |
|
|
2017
Q3 | $410M | Sell |
2,169,343
-104,206
| -5% | -$18.9M | 1.36% | 17 |
|
|
2017
Q2 | $397M | Buy |
2,273,549
+70,947
| +3% | +$11.9M | 1.21% | 25 |
|
|
2017
Q1 | $338M | Buy |
2,202,602
+1,930,759
| +710% | +$295M | 1.15% | 21 |
|
|
2016
Q4 | $38.4M | Buy |
271,843
+20,133
| +8% | +$2.97M | 0.14% | 143 |
|
|
2016
Q3 | $40M | Buy |
251,710
+12,932
| +5% | +$1.99M | 0.14% | 130 |
|
|
2016
Q2 | $35.3M | Sell |
238,778
-2,656
| -1% | -$392K | 0.12% | 135 |
|
|
2016
Q1 | $34.2M | Buy |
241,434
+9,791
| +4% | +$1.31M | 0.12% | 128 |
|
|
2015
Q4 | $32.9M | Buy |
231,643
+17,428
| +8% | +$2.32M | 0.11% | 136 |
|
|
2015
Q3 | $26.2M | Buy |
214,215
+15,775
| +8% | +$2.06M | 0.09% | 153 |
|
|
2015
Q2 | $25.7M | Sell |
198,440
-4,130
| -2% | -$538K | 0.08% | 165 |
|
|
2015
Q1 | $27.2M | Sell |
202,570
-2,715
| -1% | -$350K | 0.09% | 162 |
|
|
2014
Q4 | $25.7M | Buy |
205,285
+51,729
| +34% | +$6.29M | 0.08% | 167 |
|
|
2014
Q3 | $18.7M | Buy |
153,556
+6,727
| +5% | +$818K | 0.06% | 196 |
|
|
2014
Q2 | $17.3M | Buy |
146,829
+14,672
| +11% | +$1.73M | 0.05% | 204 |
|
|
2014
Q1 | $15.9M | Buy |
132,157
+94,814
| +254% | +$11.3M | 0.05% | 210 |
|
|
2013
Q4 | $4.16M | Buy |
37,343
+6,680
| +22% | +$664K | 0.01% | 341 |
|
|
2013
Q3 | $2.83M | Sell |
30,663
-2,350
| -7% | -$213K | 0.01% | 374 |
|
|
2013
Q2 | $2.79M | Buy |
+33,013
| New | +$2.75M | 0.01% | 363 |
|
Other funds holding TMO
VCM
Brown Advisory's TMO Position: Q1 2026 in Review
Brown Advisory increased its Thermo Fisher Scientific (TMO) stake by 3.6% in Q1 2026, buying an estimated $1.74M and bringing the position to 92,433 shares worth $45.4M. The position accounts for 0.07% of the portfolio, ranked #206.
Brown Advisory first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.69B in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Brown Advisory held 92,433 shares of Thermo Fisher Scientific worth $45.4M as of Q1 2026.
- Brown Advisory bought 3,214 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.74M.
- Thermo Fisher Scientific made up 0.07% of Brown Advisory's portfolio in Q1 2026, its #206 holding.
- Brown Advisory first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Brown Advisory's Thermo Fisher Scientific position peaked at $1.69B in Q4 2021.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.